Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis.
Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Sinha P, et al. Among authors: padmapriyadarsini c. Clin Infect Dis. 2023 Apr 17;76(8):1483-1491. doi: 10.1093/cid/ciac915. Clin Infect Dis. 2023. PMID: 36424864 Free PMC article.
Role for Linezolid in drug sensitive tuberculosis.
Ramesh Kumar S, Narendran G, Padmapriyadarsini C. Ramesh Kumar S, et al. Among authors: padmapriyadarsini c. J Infect Public Health. 2024 Jan;17(1):172-174. doi: 10.1016/j.jiph.2023.11.012. Epub 2023 Nov 13. J Infect Public Health. 2024. PMID: 38039860 Free article. Review.
Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.
Gopalaswamy R, Palani N, Viswanathan D, Preysingh B, Rajendran S, Vijayaraghavan V, Thangavel K, Vadivel SD, Stanley H, Thiruvengadam K, Jayabal L, Murugesan K, Rathinam S, Frederick A, Sivaramakrishnan G, Padmapriyadarsini C, Shanmugam S. Gopalaswamy R, et al. Among authors: padmapriyadarsini c. Medicina (Kaunas). 2023 May 23;59(6):1005. doi: 10.3390/medicina59061005. Medicina (Kaunas). 2023. PMID: 37374209 Free PMC article.
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes.
Paradkar MS, Pradhan NN, Balaji S, Gaikwad SN, Chavan A, Dharmashale SN, Sahasrabudhe T, Lokhande R, Deshmukh SA, Barthwal M, Atre S, Raskar SS, Sawant TU, Gupte AN, Kakrani A, Golub J, Padmapriyadarsini C, Gupta A, Gupte NA, Mave V. Paradkar MS, et al. Among authors: padmapriyadarsini c. Ann Am Thorac Soc. 2023 Dec;20(12):1760-1768. doi: 10.1513/AnnalsATS.202302-144OC. Ann Am Thorac Soc. 2023. PMID: 38038600 Free PMC article.
NATCON 2022 Panel discussion: "TB vaccination - Going Forward".
Banurekha VV, Padmapriyadarsini C, Bhargava S, Sachdeva K. Banurekha VV, et al. Among authors: padmapriyadarsini c. Indian J Tuberc. 2023 Jul;70(3):366-369. doi: 10.1016/j.ijtb.2023.03.022. Epub 2023 Apr 11. Indian J Tuberc. 2023. PMID: 37562914
Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India.
Velayutham B, Jayabal L, Watson B, Jagadeesan S, Suresh C, Nair D, Gopalaswamy R, Devaleenal B, Selvaraju S, Padmapriyadarsini C. Velayutham B, et al. Among authors: padmapriyadarsini c. Indian J Community Med. 2023 Jan-Feb;48(1):103-107. doi: 10.4103/ijcm.ijcm_315_22. Epub 2023 Feb 1. Indian J Community Med. 2023. PMID: 37082398 Free PMC article.
121 results